Influence of the ultrasound in cutaneous permeation of the caffeine: In vitro study

Pharmacologyonline

Volumn 1, Issue , 2007, Pages 477-486

  Pires de Campos, M S M ^a,b   Polacow, M L O ^b   Granzotto, T M ^b   Spadari Bratfisch, R C ^a   Leonardi, G R ^b   Grassi Kassisse, D M ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b METHODIST UNIVERSITY OF PIRACICABA   (Brazil)

Author keywords

Caffeine; Cutaneous permeation; Phonophoresis; Skin swine; Ultrasound

Indexed keywords

ACETIC ACID; ALCOHOL; CAFFEINE; CARBOMER; IVERMECTIN; PROPYLENE GLYCOL; TRIETHANOLAMINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG FORMULATION; DRUG PENETRATION; GEL; MALE; NONHUMAN; PARASITOSIS; SKIN PENETRATION; SPECTROPHOTOMETER; SWINE; ULTRASOUND;

EID: 34249712887     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Asbill C.S., El-Kattan A.F., Michniak B. Enhancement of transdermal drug delivery:chemical and physical approaches. Crit Ver Ther Drug Carrier Syst. 2000; 17:621-658.
2. Byl N.N. The Use of ultrasound as an enhancer for transcutaneous drug delivery: Phonophoresis. Phys Ther. 1995; 75:89-103.
3. Mitragotri S. Synergistic effect of enhancers for transdermal drug delivery. Pharm Res. 2000; 17:1354-1359.
4. Tang H., Mitragotri S., Blankschtein D., Langer R. Theoretical description of transdermal transport of hydrophilic permeants: Application to low-frequency sonophoresis. J Pharm Sciences. 2001; 90:545-568.
5. Machet L., Boucaud A. Phonophoresis: efficiency, mechanisms and skin tolerance. Int J Pharm 2002; 243:1-15
6. Morimoto Y., Sugibayashi K., Natsume H. The transdermal drug delivery system and transcutaneous absorption. Acta Derm Venered Suppl (Stockh) 1994;185:15-17.
7. Ueda H., Ogihara M., Sugibayashi K., Morimoto Y. Difference in the enhancing effects of ultrasound on the skin permeation of polar and non-polar drugs. Chem Pharm Bull 1996; 44:1973-1976.
8. Hippius M., Smolenski U., Uhlemann C., Schreiber U., Hoffmann A. Investigations of drug release and penetration- enhancing effect of ultra-sound on transmembrane transport of fluofenamic acid. Exp Toxicol Pathol 1998; 50 (4-6):450-452.
9. Fang J, Fang C, Sung KC, Chen H. Effect of low frequency ultrasound on the in vitro percutaneous absorption of clobetasol 17-propionate. Int J Pharm. 1999; 191:33-42.
10. Bommannan D., Okuyama H., Stauffer P., Guy R.H. Sonophoresis, I: the use of high-frequency ultrasound to enhance transdermal drug delivery. Pharm Res 1992; 9:559-564.
11. Bommannan D., Menons G.K., Okuyama H. Sonophoresis, II: examination of the mechanisms(s) of ultrasound-enhanced transdermal drug delivery. Pharm Res 1992; 9:1043-1047.
12. Mitragotri S., Blankschtein D., Langer R. Transdermal drug delivery_using low frequency sonophoresis. Pharm Res 1996; 13:411-420.
13. Kassan D.G., Lunch A.M., Stiller M.J. Physical enhancement of dermatologic drug delivery: Iontohoresis and phonophoresis. J Am Acad Dermatol 1996; 34:657-666.
14. Sinclair C., Geiger J. Caffeine use in sports; a pharmacological review. J Sports Med Phys Fitnes 2000; 40:71-79.
15. Dias M., Farinha A., Faustino E., et al. Topical delivery of caffeine from some commercial formulations. Int J Pharm 1999; 182:41-47.
16. Boucaud A., Machet L., Arbeile B., et al. In vitro study of low-frequency ultrasound-enhanced transdermal transport of fentanyl and caffeine across human and hairless rat skin. Int J Pharm 2001; 228:69-77.
17. Monti D., Giannelli R., Chetoni P., Burgalassi S. Comparison of the effect of ultrasound on transdermal permeation of caffeine and morphine through hairless mouse skin in vitro. Int J Pharm 2001; 229:131-137.
18. Tholon L., Neliat G., Chesne C., et al. An in vitro, ex vivo, and in vivo demonstration of the lipolytic effect of slimming liposomes: An unexpected alpha(2)-adrenergic antagonism. J Cosmetic Sci 2002; 53:209-218
19. Bentley M.V.L.B. Desenvolvimento de produtos dermatológicos contendo corticosteróides: avaliação da liberação e penetração transcutânea por metodologia in vitro. Tese de Doutorado. Faculdade de Ciências Farmacêuticas - Universidade de São Paulo, 1994.
20. Olfert E.D., Cross B.M., McWilliam A.A. Guide to the care use the experimental animals. Canadian council on animal care 213, Ottawa, Ontario, 1993.
21. Fyfe M.C. A study of the effects of different ultrasonic frequencies on experimental edema. Aust J Physiother 1979; 25:205-207.
22. Williams A.R. Ultrasound Biologic effects and potential hazards. Academic Press, New York, 1983.
23. Cameron M.H., Manroe L.G. Relative transmission of ultrasound by media customarily used by phonophoresis. Phys Ther 1992; 72:142-148.
24. Oakley E.M. Application of continuous beam of ultrasound at therapeutic levels. Physiother 1978; 68:169-172.
25. Byl N.N., Mckenzie A., Halliday B., Wong T., O'Connell J.O. The effects of phonophoresis with corticosteroids: a controlled pilot study. J Orthop Sport Phys Ther 1993; 18:590-600.
26. Guirro R.R.J., Cancelieri A.S., Sant'Anna I.L. Avaliação dos meios intermediários utilizados na aplicação do ultra-som terapêutico. Rev. Bras. Fisioter 2001; 5:49-52.
27. Zar J.H., Biostatistical Analysis. 2nd ed. Hall International, Upper Saddle River, NJ, 1984.
28. Snedecor G.W., Cochran W.G. Statistical Methods. 6Th Ed. Iowa State University Press. IA. 1967:342-343.
29. Matthews J.N.S., Altman D.G., Campbell M., Royston P. Analysis of serial measurements in medical research. Brit Med J 1990; 27:233-235.
30. Mitragotri S., Edwards DA, Blankschtein D., Langer R. A mechanistic study of ultrasonically enhanced transdermal delivery. J Pharm Sci 1995; 84:697-706.
31. Bronaugh R. L, Stewart R. F., Congdon E. R.; Methods for In Vitro percutaneous absorption studies. II. Animal models for human skin. Toxicol Appl Pharmacol 1982; 62:481-488.
32. Johnson M.E, Mitragotri S., Patel A, Blankschtein D., Langer R. Synergistic effects of chemical enhancers and therapeutic ultrasound on transdermal drug delivery. J Pharm Sci 1996; 85:670-679
33. Edwards D, Langer R. A linear theory of transdermal phenomena. J Pharm Sci 1994; 83:1315-1334.
34. Boucaud A., Montharu L, Machet L., et al. Clinical histologic and electron microscopic study of skin exposed to low-frequency ultrasound. Anat Rec 2001; 264:114-119.
35. Kost J, Levy D, Langer R. Ultrasound as a transdermal enhancer. In: Bronaug R. L., Maibach H. I., Percutaneous Absorption; Mechanism - Methodology - Drug Delivery. 2 ed. New York, Marcel Dekker, 1989:595-601.
36. Levang A.K, Zhao K., Singh J. Effect of ethanol/propylene glycol on the in vitro percutaneous absorption of aspirin, biophysical changes and macroscopic barrier properties of the skin. Int J Pharm. 1999; 181:255-263.
37. Carver M.P., Williams P.L.,. Riviere J.E. The Isolated Perfused Porcine Skin Flap. Toxicol. Ap Pharm. 1997; 97:324-337.